Literature DB >> 16165214

Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration.

Judy P Q Zhu1, Wenjing Xu, Nieves Angulo, Jesus A Angulo.   

Abstract

Methamphetamine (METH) is a psychostimulant that induces neural damage in experimental animals and humans. A binge (usually in the 5-10 mg/kg dose range 4 x at 2 h intervals) and the acute bolus drug administration (20-40 mg/kg) of METH have been employed frequently to study neurotoxicity in the brain. In this study we have compared these drug delivery schedules to determine their efficacy to induce striatal apoptosis. Exposure of male mice to a binge of METH at 10mg/kg 4x at 2 h intervals (cumulative dose of 40 mg/kg) was approximately four times less effective in inducing apoptotic cell death (TUNEL staining) 24 h after METH treatment in the striatum than a single bolus administration of 30 mg/kg of METH. The residual TUNEL staining observed three days after METH treatment is proportionately equivalent between a binge and the acute bolus drug administration. Interestingly, a binge of METH induces a hyperthermic response of longer duration. This study demonstrates that an acute bolus drug administration of METH is more effective inducing striatal apoptosis in mice, and therefore, is more suitable for studies assessing the impact of METH on sites post-synaptic to the striatonigral dopamine terminals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165214      PMCID: PMC2896282          DOI: 10.1016/j.neuro.2005.05.014

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  28 in total

1.  Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Tao Xie; Liqiong Tong; Tanya Barrett; Jie Yuan; George Hatzidimitriou; Una D McCann; Kevin G Becker; David M Donovan; George A Ricaurte
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase.

Authors:  S Z Imam; G D Newport; Y Itzhak; J L Cadet; F Islam; W Slikker; S F Ali
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

3.  Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study.

Authors:  T Ernst; L Chang; M Leonido-Yee; O Speck
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

4.  Central nervous system cytopathological changes in cats with chronic methedrine intoxication.

Authors:  O D Escalante; E H Ellinwood
Journal:  Brain Res       Date:  1970-06-30       Impact factor: 3.252

5.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 6.  Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.

Authors:  C Davidson; A J Gow; T H Lee; E H Ellinwood
Journal:  Brain Res Brain Res Rev       Date:  2001-08

7.  Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method.

Authors:  X Deng; Y Wang; J Chou; J L Cadet
Journal:  Brain Res Mol Brain Res       Date:  2001-09-10

8.  Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process.

Authors:  John F Bowyer; Angela J Harris; Robert R Delongchamp; Robert L Jakab; Diane B Miller; A Roger Little; James P O'Callaghan
Journal:  Neurotoxicology       Date:  2004-06       Impact factor: 4.294

9.  Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.

Authors:  Jing Yu; Jing Wang; Jean Lud Cadet; Jesus A Angulo
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

10.  Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.

Authors:  Jing Yu; Jean Lud Cadet; Jesus A Angulo
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

View more
  36 in total

1.  Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.

Authors:  Seong-Jin Yu; Mikko Airavaara; Hui Shen; Jenny Chou; Brandon K Harvey; Yun Wang
Journal:  Psychopharmacology (Berl)       Date:  2011-12-13       Impact factor: 4.530

2.  A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.

Authors:  H Shen; A Mohammad; J Ramroop; S S Smith
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

3.  9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons.

Authors:  David J Reiner; Seong-Jin Yu; Hui Shen; Yi He; Eunkyung Bae; Yun Wang
Journal:  Neurotox Res       Date:  2013-07-25       Impact factor: 3.911

4.  Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice.

Authors:  Ingrid Tulloch; Nane Ghazaryan; Ina Mexhitaj; Dalila Ordonez; Jesus A Angulo
Journal:  Brain Res       Date:  2011-05-15       Impact factor: 3.252

5.  Glial reactivity in resistance to methamphetamine-induced neurotoxicity.

Authors:  Danielle M Friend; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-03-17       Impact factor: 5.372

6.  Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.

Authors:  Nicholas B Miner; Josh S Elmore; Michael H Baumann; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicology       Date:  2017-09-15       Impact factor: 4.294

7.  Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

Authors:  J P Q Zhu; W Xu; J A Angulo
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

8.  Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.

Authors:  Eun-Joo Shin; Seung Woo Shin; Thuy-Ty Lan Nguyen; Dae Hun Park; Myung-Bok Wie; Choon-Gon Jang; Seung-Yeol Nah; Byung Wook Yang; Sung Kwon Ko; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2014-01-16       Impact factor: 5.590

9.  PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice.

Authors:  Eun-Joo Shin; Duy-Khanh Dang; Hai-Quyen Tran; Yunsung Nam; Ji Hoon Jeong; Young Hun Lee; Kyung Tae Park; Yong Sup Lee; Choon-Gon Jang; Jau-Shyong Hong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2016-09-10       Impact factor: 3.921

10.  Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.

Authors:  Brandon K Harvey; Jenny Chou; Hui Shen; Barry J Hoffer; Yun Wang
Journal:  Neurotoxicology       Date:  2009-02-13       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.